^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Strata Select™

    Company:
    Strata Oncology
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    1year
    Strata Oncology Announces Launch and Medicare Coverage for Strata Select, a First-of-its-kind Immunotherapy Test (PRNewswire)
    "Strata Oncology, Inc...today announced the launch of Strata Select™, a first-of-its-kind molecular profiling test for patients with advanced cancer. The new diagnostic test features the Immunotherapy Response Score, a novel multivariate predictive biomarker algorithm for anti-PD-1/PD-L1 checkpoint inhibitor immunotherapy benefit....The Immunotherapy Response Score integrates relevant biological factors (TMB, PD-L1, PD-1, and tumor microenvironment components) into a simple score to predict immunotherapy benefit across all solid tumors."
    Medicare • Launch • Reimbursement
    |
    Strata Select™